Tuesday, 15 September 2009

Loestrin 24 Fe and Femcon Fe: Innovator sued Lupin for Para IV filing

Innovator M/S Warner Chilcott announced (in a press release Here ) that one of its subsidiaries has filed lawsuits against Indian generic player M/S Lupin Pharma in the District Court for the District of Delaware for infringement of Warner Chilcott's U.S. Patent Nos. 5,552,394 (Expiry: in July 2014) and 6,667,050 (Expiry April 2019), which cover oral contraceptives Loestrin 24 Fe (Norethindrone acetate and Ethinyl estradiol tablets, USP and ferrous fumarate tablets) and Femcon Fe (Norethindrone, Ethinyl estradiol tablets, ferrous fumarate tablets), respectively
Earlier review on this product Here.

Posted by ADKS at 4:23 pm

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)
web page statistics
Disclaimer: "IP Pharma Doc" blog is published for information purpose only. "IP Pharma Doc" blog contains no legal advice. I assume no legal responsibility for the views/information expressed here. “IP Pharma Doc” blog is my personal website and not edited by my employer, accordingly, no part of my blog should be attributed to my employer. All information on the present blog should be double checked for its accuracy and applicability. © Dr. Sarwal (2007)
 
eXTReMe Tracker